Timing of hormone therapy and its association with cardiovascular risk and metabolic parameters in 4-vinylcyclohexene diepoxide-induced primary ovarian insufficiency mouse model.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology(2023)

引用 0|浏览6
暂无评分
摘要
On-time, continuous E2 treatment immediately after a biologic estrogen deprivation event significantly reduced metabolic and cardiovascular risks in young, pre-menarche female mouse models of POI, confirming decreased serum levels of pro-inflammatory cytokines.
更多
查看译文
关键词
Hormone therapy, timing hypothesis, primary ovarian insufficiency, metabolic syndrome, cardiovascular disease, 4-vinylcyclohexene diepoxide, >
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要